

Cover Story
Capitol Hill
By Paul Goldberg and Jacquelyn Cobb
The House Republicans have narrowly pushed through a FY25 budget resolution, setting off a tangle of life-and-death sequelae for access to health insurance through Medicaid and Obamacare, and through a second-order effect, biomedical research.
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets


Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
- Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field



















